Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.08%
SPX
-0.22%
IXIC
-0.51%
FTSE
-0.20%
N225
-0.22%
AXJO
-0.21%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
2.01M
Dividend Yield
0.00%
P/E Ratio
-0.36
EPS
-7.07
Revenue
-
Avg. Volume
29.93K

Recently from Cashu

publisher logo
Cashu

Salarius Pharmaceuticals Secures Nasdaq Extension to Address Compliance and Innovate Cancer Treatments

1 day ago
publisher logo
Cashu

Salarius Pharmaceuticals (SLRX) Receives Conditional Nasdaq Extension Amid Compliance Challenges

3 days ago
publisher logo
Cashu

Salarius Pharmaceuticals Embraces AI for Enhanced Communication in Biopharmaceuticals

5 months ago

About

What does SLRX do?
Salarius Pharmaceuticals, a clinical-stage biopharmaceutical company based in Houston, Texas, focuses on developing innovative cancer treatments, including seclidemstat and SP-3164. The company went public on January 29, 2015.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
Texas, USA
Website
http://www.salariuspharma.com
Stocks
Health Care
slrx
Salarius Pharmaceuticals
SLRX
+0.08 (+7.87%)
1.165
USD
At close at Jun 20, 20:40 UTC
Summary
News
Signals
Benchmarks
Financials